Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | LY4584180 |
| Synonyms | |
| Therapy Description |
Limited information is currently available on LY4584180, a putative BCL6 molecular glue (Nov 2025). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| LY4584180 | LY-4584180|LY 4584180 | Limited information is currently available on LY4584180, a putative BCL6 molecular glue (Nov 2025). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|---|---|---|---|---|---|
| NCT07226843 | Phase I | LY4584180 + Rituximab LY4584180 | A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers | Not yet recruiting | USA | 0 |